Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

China flag China · Delayed Price · Currency is CNY
56.55
+0.96 (1.73%)
Sep 30, 2025, 3:00 PM CST
1.73%
Market Cap71.54B
Revenue (ttm)1.72B
Net Income (ttm)-298.28M
Shares Out1.27B
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,648,168
Average Volume4,533,694
Open55.79
Previous Close55.59
Day's Range55.59 - 56.73
52-Week Range54.24 - 89.89
Beta1.30
RSI44.34
Earnings DateOct 30, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells vitro diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. It also provides HPV, hepatitis E, and nasal spray COVID-19 vaccine. In addition, the company offers bio-immune and immunoassay... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 3,790
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603392
Full Company Profile

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.

Financial Statements

News

There is no news available yet.